Teicoplanin (0-2 g) or vancomycin (1 g) were infused over 3 and 50 min respectively to six male volunteers in a cross-over study. Each drug was administered twice at a 14 h interval. The pharmacolcinetics of both drugs were accurately described using a two-compartment model. Vancomycin had a shorter half-life (5-8 ± 1-8 h) compared to teicoplainin (33-2±51h; P<0001) One hour serum was tested for serum bactericidal activity against ten strains each of Staphylococcus aureus (median serum bactericidal activity 1:16 for teicoplanin; 1:32 for vancomycin), Staph. epidermidis (1:32 for teicoplanin and for vancomycin) and Streptococcus faecalis (1:2 for both drugs). Serum killing rate studies showed a slower rate of killing of Staph. aureus with...
We adapted an in vitro pharmacodynamic model of infection to incorporate simulated endocardial veget...
The prophylactic and therapeutic activities of teicoplanin were evaluated in two different experimen...
The in-vitro effects of therapeutic concentrations of teicoplanin and vancomycin on the adherence, s...
The effect of protein binding on the activity of teicoplanin against Staphylococcus aureus was evalu...
Vancomycin and teicoplanin are the glycopeptides currently in use for the treatment of infections ca...
Brusseb, Belgium Twenty-one patients were included in an open randomized study comparing vancomycin ...
In a prospective, randomized, double-blind study comparing teicoplanin and vancomycin for the treatm...
ObjectiveTo investigate the basic pharmacodynamic properties of teicoplanin in vitro for Staphylococ...
Objective To investigate the basic pharmacodynamic properties of teicoplanin in vitro for Staphyloco...
15th European Congress of Clinical Microbiology and Infectious Diseases -- APR 02-05, 2005 -- Copenh...
Teicoplanin and vancomycin are antibiotics widely used in the therapy of bone and joint infections. ...
Nosocomial isolates of staphylococci and enterococci were studied for their antimicrobial susceptibi...
Ninety-one clinical isolates of Staphylococcus aureus have been tested with the Kirby Bauer and the ...
2 Background: Vancomycin and teicoplanin are the glycopeptides currently in use for invasive beta-la...
Objective: To compare the efficacy of teicoplanin with that of vancomycin in patients with proven or...
We adapted an in vitro pharmacodynamic model of infection to incorporate simulated endocardial veget...
The prophylactic and therapeutic activities of teicoplanin were evaluated in two different experimen...
The in-vitro effects of therapeutic concentrations of teicoplanin and vancomycin on the adherence, s...
The effect of protein binding on the activity of teicoplanin against Staphylococcus aureus was evalu...
Vancomycin and teicoplanin are the glycopeptides currently in use for the treatment of infections ca...
Brusseb, Belgium Twenty-one patients were included in an open randomized study comparing vancomycin ...
In a prospective, randomized, double-blind study comparing teicoplanin and vancomycin for the treatm...
ObjectiveTo investigate the basic pharmacodynamic properties of teicoplanin in vitro for Staphylococ...
Objective To investigate the basic pharmacodynamic properties of teicoplanin in vitro for Staphyloco...
15th European Congress of Clinical Microbiology and Infectious Diseases -- APR 02-05, 2005 -- Copenh...
Teicoplanin and vancomycin are antibiotics widely used in the therapy of bone and joint infections. ...
Nosocomial isolates of staphylococci and enterococci were studied for their antimicrobial susceptibi...
Ninety-one clinical isolates of Staphylococcus aureus have been tested with the Kirby Bauer and the ...
2 Background: Vancomycin and teicoplanin are the glycopeptides currently in use for invasive beta-la...
Objective: To compare the efficacy of teicoplanin with that of vancomycin in patients with proven or...
We adapted an in vitro pharmacodynamic model of infection to incorporate simulated endocardial veget...
The prophylactic and therapeutic activities of teicoplanin were evaluated in two different experimen...
The in-vitro effects of therapeutic concentrations of teicoplanin and vancomycin on the adherence, s...